These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8161973)

  • 21. [Public health management in invasive meningococcal diseases].
    Ehrhard I; Arndt U
    Gesundheitswesen; 2004 Dec; 66(12):790-5. PubMed ID: 15609213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Meningococcal diseases in Austria].
    Thiel W; Haas G; Heuberger S
    Wien Klin Wochenschr; 1998 Jun; 110(12):415-22. PubMed ID: 9677660
    [No Abstract]   [Full Text] [Related]  

  • 23. [Meningococcal disease in the Faroe Islands during the period 1978-1985].
    Mathiassen B; Weihe PM; Rasmussen JM; Petersen TV; Isager H
    Ugeskr Laeger; 1990 May; 152(19):1360-2. PubMed ID: 2343491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningococcal disease in Auckland, July 1992 - June 1994.
    Jefferies C; Lennon D; Stewart J; Martin D
    N Z Med J; 1999 Apr; 112(1085):115-7. PubMed ID: 10326799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serogroup Y meningococcal disease, Colombia.
    Inés Agudelo C; Sanabria OM; Ovalle MV
    Emerg Infect Dis; 2008 Jun; 14(6):990-1. PubMed ID: 18507927
    [No Abstract]   [Full Text] [Related]  

  • 26. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 27. [Meningococcal infections: aspects of microbiology, epidemiology and prevention].
    Ehrhard I; Sonntag HG
    Gesundheitswesen; 1999 Oct; 61 Spec No 1():S41-5. PubMed ID: 10593044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines.
    National Advisory Committee on Immunisation (NACI)
    Can Commun Dis Rep; 2001 Oct; 27():2-36. PubMed ID: 11706686
    [No Abstract]   [Full Text] [Related]  

  • 29. [Epidemiology and prognosis of severe meningococcal infections. Description of 112 cases].
    Bernaola E; Delgado A; Muñoz M; Viscoli C
    Minerva Pediatr; 1981 Nov; 33(22):1075-80. PubMed ID: 7335021
    [No Abstract]   [Full Text] [Related]  

  • 30. Meningococcal disease in Australia: 1997 and beyond.
    Harvey BM
    Commun Dis Intell; 1998 Jul; 22(7):134-5. PubMed ID: 9684531
    [No Abstract]   [Full Text] [Related]  

  • 31. Meningitis: public health issues.
    Gunn A; Hollyoak V
    Nurs Times; 1996 Feb 7-14; 92(6):27-9. PubMed ID: 8684977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of meningococcal infections in children in Loire-Atlantique and neighbouring areas from 1997 to 2002].
    Courtin V; Liet JM; Prat M; Picherot G; Rozé JC
    Arch Pediatr; 2005 Mar; 12(3):330. PubMed ID: 15734132
    [No Abstract]   [Full Text] [Related]  

  • 33. Marijuana use and social networks in a community outbreak of meningococcal disease.
    Krause G; Blackmore C; Wiersma S; Lesneski C; Woods CW; Rosenstein NE; Hopkins RS
    South Med J; 2001 May; 94(5):482-5. PubMed ID: 11372796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningococcemia in a group of Canadian students on a European trip.
    Schaaf L; Baur EM; Kusterer K; Huc K; Bode H; Rohr G; Usadel KH
    Can Dis Wkly Rep; 1989 Nov; 15(46):229-31. PubMed ID: 2582527
    [No Abstract]   [Full Text] [Related]  

  • 35. [Meningococcus, serogroup C].
    Noack R
    Krankenpfl J; 2005; 43(1-3):16. PubMed ID: 15912812
    [No Abstract]   [Full Text] [Related]  

  • 36. Multicenter surveillance of invasive meningococcal infections in children.
    Kaplan SL; Schutze GE; Leake JA; Barson WJ; Halasa NB; Byington CL; Woods CR; Tan TQ; Hoffman JA; Wald ER; Edwards KM; Mason EO
    Pediatrics; 2006 Oct; 118(4):e979-84. PubMed ID: 17015517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004.
    Moore DL; Vaudry W; Scheifele DW; Halperin SA; Déry P; Ford-Jones E; Arishi HM; Law BJ; Lebel M; Le Saux N; Grimsrud K; Tam T
    Pediatrics; 2006 Sep; 118(3):e610-9. PubMed ID: 16950953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.
    Squires SG; Pelletier L; Mungai M; Tsang R; Collins F; Stoltz J
    Can Commun Dis Rep; 2000 Nov; 26(21):177-82. PubMed ID: 11107657
    [No Abstract]   [Full Text] [Related]  

  • 39. [Epidemiology and clinic of meningococcal infections. Indications for immunization].
    Goetz O; Peller P
    MMW Munch Med Wochenschr; 1980 Oct; 122(41):1411-2. PubMed ID: 6780820
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.